Literature DB >> 21900000

Pulmonary alveolar proteinosis: new insights from a single-center cohort of 70 patients.

Francesco Bonella1, Peter C Bauer, Matthias Griese, Shinichiro Ohshimo, Josune Guzman, Ulrich Costabel.   

Abstract

BACKGROUND: Pulmonary alveolar proteinosis (PAP) is a rare syndrome characterized by the intra-alveolar accumulation of surfactant lipids and proteins. The aim of the study is to describe the epidemiologic, clinical, physiologic, and laboratory features of PAP in a large single-center cohort of patients with PAP. STUDY POPULATION: Over 30 years, 70 patients with PAP were managed at our institution, 64 with primary and 6 with secondary PAP.
RESULTS: The mean age at diagnosis was 43 years with a male to female ratio of 1.3. BAL was the most commonly applied diagnostic method, performed in 83% of cases. A history of smoking was seen in 79%, and of dust exposure in 54%, most commonly to aluminum, silica and sawdust. GM-CSF autoantibody correlated with clinical outcome and KL-6 with diffusing capacity. The number of whole lung lavages (WLL) necessary to reach remission was higher in current smokers.
CONCLUSIONS: This study shows that the use of BAL for the diagnosis of PAP can reduce the need of histological confirmation. A history of dust or fume inhalation is strongly associated with PAP, also with the autoimmune form. Smoking seems to influence the response to treatment, increasing the number of WLL necessary to reach remission.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21900000     DOI: 10.1016/j.rmed.2011.08.018

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  30 in total

1.  Milky fluid from the lungs: pulmonary alveolar proteinosis.

Authors:  Divya P Nimmatoori; Saurabh Bansal; Namrata Singhania; Anil K Singh; Vijay Mohan Sudigali
Journal:  Intern Emerg Med       Date:  2020-08-31       Impact factor: 3.397

2.  A case of autoimmune pulmonary alveolar proteinosis with fluctuating lung shadows in parallel with cigarette smoke burden.

Authors:  Takahashi Ayumu; Yamaguchi Etsuro; Yonezawa Toshiyuki; Kosaka Kenshi; Matsubara Ayako; Nishimura Masaki; Tanaka Hiroyuki; Yokoe Norihito; Kubo Akihito
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-09       Impact factor: 0.670

Review 3.  Smoking-related interstitial lung disease.

Authors:  Lars Hagmeyer; Winfried Randerath
Journal:  Dtsch Arztebl Int       Date:  2015-01-23       Impact factor: 5.594

4.  Nocardial brain abscess in a patient with pulmonary alveolar proteinosis.

Authors:  Kiana Shirani; Asger Nyborg Poulsen; Atousa Hakamifard
Journal:  Adv Biomed Res       Date:  2015-08-31

Review 5.  Pulmonary Alveolar Proteinosis Syndrome.

Authors:  Takuji Suzuki; Bruce C Trapnell
Journal:  Clin Chest Med       Date:  2016-06-17       Impact factor: 2.878

6.  Increased Efficacy of Whole Lung Lavage Treatment in Alveolar Proteinosis Using a New Modified Lavage Technique.

Authors:  L Agnes Grutters; Elseline C Smith; Cees W Casteleijn; Eric P van Dongen; Henk J Ruven; Joanne J van der Vis; Marcel Veltkamp
Journal:  J Bronchology Interv Pulmonol       Date:  2021-07-01

7.  Efficacy of whole lung lavage in pulmonary alveolar proteinosis: a 20-year experience at a reference center in Thailand.

Authors:  Punchalee Kaenmuang; Asma Navasakulpong
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

8.  Assessment and management of pulmonary alveolar proteinosis in a reference center.

Authors:  Ilaria Campo; Francesca Mariani; Giuseppe Rodi; Elena Paracchini; Eric Tsana; Davide Piloni; Isabella Nobili; Zamir Kadija; Angelo Corsico; Isa Cerveri; Claudia Chalk; Bruce C Trapnell; Antonio Braschi; Carmine Tinelli; Maurizio Luisetti
Journal:  Orphanet J Rare Dis       Date:  2013-03-13       Impact factor: 4.123

9.  Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosis.

Authors:  Francesco Bonella; Shinichiro Ohshimo; Cai Miaotian; Matthias Griese; Josune Guzman; Ulrich Costabel
Journal:  Orphanet J Rare Dis       Date:  2013-04-04       Impact factor: 4.123

10.  GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disorders.

Authors:  Matthias Griese; Ralf Zarbock; Ulrich Costabel; Jenna Hildebrandt; Dirk Theegarten; Michael Albert; Antonia Thiel; Andrea Schams; Joanna Lange; Katazyrna Krenke; Traudl Wesselak; Carola Schön; Matthias Kappler; Helmut Blum; Stefan Krebs; Andreas Jung; Carolin Kröner; Christoph Klein; Ilaria Campo; Maurizio Luisetti; Francesco Bonella
Journal:  BMC Pulm Med       Date:  2015-08-12       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.